Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin versus rosuvastatin in acute ischemic stroke
IRCT20181009041286N2Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Atorvastatin arm with Rosuvastatin arm (2 arms). Primary endpoints: Erythrocyte sedimentation rate, C-reactive protein and 3 more. Started Oct 2021; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20181009041286N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181009041286N2.